VolitionRx Ltd
VNRX
26 hedge funds and large institutions have $4.84M invested in VolitionRx Ltd in 2024 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 4 closing their positions.
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
8% more funds holding
Funds holding: 24 → 26 (+2)
0.01% more ownership
Funds ownership: 0.47% → 0.48% (+0.01%)
18% less capital invested
Capital invested by funds: $5.89M → $4.84M (-$1.06M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIM
Lagoda Investment Management
New York
|
+$267K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$28.2K |
| 3 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
+$18.8K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$12.6K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$8.77K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$42.2K |
| 2 |
SAMC
Spectrum Asset Management (California)
Newport Beach,
California
|
-$42.1K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$36.7K |
| 4 |
Morgan Stanley
New York
|
-$32.8K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$21.3K |
VNRX Hedge Fund Activity: Q2 2024 in Review
26 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q2 2024, worth a combined $4.84M — down 18% from $5.89M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new VNRX positions and 4 closed out — a net gain of 2 holders — while 7 added to existing stakes and 6 trimmed.
The largest buyer was Lagoda Investment Management, adding an estimated $267K. The largest seller was BlackRock, cutting an estimated $42.2K.
- 26 institutional investors held VolitionRx Ltd (VNRX) as of Q2 2024, up from 24 in Q1 2024.
- Funds reported $4.84M of VolitionRx Ltd stock for Q2 2024, down 18% quarter-over-quarter.
- 6 funds opened new VolitionRx Ltd positions in Q2 2024 and 4 closed out, a net change of +2 holders.
- The largest VolitionRx Ltd buyer in Q2 2024 was Lagoda Investment Management, an estimated $267K added.
- The largest VolitionRx Ltd seller in Q2 2024 was BlackRock, an estimated $42.2K sold.
Based on aggregated 13F filings for Q2 2024.